0001127602-22-026326.txt : 20221123 0001127602-22-026326.hdr.sgml : 20221123 20221123145316 ACCESSION NUMBER: 0001127602-22-026326 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220801 FILED AS OF DATE: 20221123 DATE AS OF CHANGE: 20221123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vitoc Vlad CENTRAL INDEX KEY: 0001913257 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-41455 FILM NUMBER: 221415737 MAIL ADDRESS: STREET 1: 444 WEST LAKE STREET, SUITE 1700 CITY: CHICAGO STATE: IL ZIP: 60606 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MAIA Biotechnology, Inc. CENTRAL INDEX KEY: 0001878313 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 444 WEST LAKE STREET, SUITE 1700 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 312-416-8592 MAIL ADDRESS: STREET 1: 444 WEST LAKE STREET, SUITE 1700 CITY: CHICAGO STATE: IL ZIP: 60606 4/A 1 form4a.xml PRIMARY DOCUMENT X0306 4/A 2022-08-01 2022-08-02 0001878313 MAIA Biotechnology, Inc. MAIA 0001913257 Vitoc Vlad 444 WEST LAKE STREET, CHICAGO IL 60606 1 1 1 Chief Executive Officer Common Stock 2022-08-01 4 P 0 6000 5.00 A 789121 D Common Stock 2022-08-01 4 P 0 10000 5.00 A 210000 I See Footnote These shares were purchased in the issuer's initial public offering, which closed on August 1, 2022. These securities are beneficially owned by Mr. Vitoc's spouse. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. /s/ Vlad Vitoc 2022-11-23